Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors-Reference-Cited by-同舟云学术

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors

Published:2022-12-17 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Tran Bao-Tram Thi¹^ORCID,Gelin Aurore¹,Durand Sylvère²^ORCID,Texier Matthieu³,Daste Amaury⁴,Toullec Clémence⁵^ORCID,Benihoud Karim¹^ORCID,Breuskin Ingrid⁶,Gorphe Philippe⁶,Garic Florence⁷,Brenner Catherine¹^ORCID,Le Tourneau Christophe⁸^ORCID,Fayette Jérôme⁹,Niki Toshiro¹⁰^ORCID,David Muriel¹¹^ORCID,Busson Pierre¹^ORCID,Even Caroline⁶

Affiliation:

1. CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, France

2. Plateforme de Métabolomique/UMR 1138, Gustave Roussy and Université Paris-Saclay, Villejuif, France

3. Service d’Epidémiologie et de Biostatistiques, Gustave Roussy and Université Paris-Saclay, Villejuif, France

4. Department of Medical Oncology, Hôpital Saint André, Bordeaux, France

5. GI and Liver/Head and Neck unit, Institut du Cancer-Avignon Provence, Avignon, France

6. Service de Cancérologie Cervico-Faciale, Gustave Roussy, Villejuif, France

7. Department R&D, Unicancer, Paris cedex 13, France

8. Department of Drug Development and Innovation (D3i), Institut Curie and Paris-Saclay University, Paris, France

9. Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286 & Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France

10. Department of Immunology, Kagawa University, Kita-gun, Japan

11. HiFiBiO Therapeutics, Pépinière Paris Santé Cochin, Paris, France

Funder

Groupement des Entreprises Françaises dans la Lutte contre le Cancer

Bristol-Mayer-Squibbs Foundation for Research on Immuno-Oncology

Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2150472